Sirona Biochem Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SRBCF research report →
Companywww.sironabiochem.com
Sirona Biochem Corp. , a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects include the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
- CEO
- Howard J. Verrico
- IPO
- 2013
- Employees
- 10
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $1.63M
- P/E
- -0.70
- P/S
- 64.69
- P/B
- -0.70
- EV/EBITDA
- -1.66
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -82.71%
- Op Margin
- -6917.60%
- Net Margin
- -7312.43%
- ROE
- 221.45%
- ROIC
- 1259.21%
Growth & Income
- Revenue
- $34.78K · -94.82%
- Net Income
- $-2,543,190 · 28.52%
- EPS
- $-0.01 · 31.76%
- Op Income
- $-2,405,872
- FCF YoY
- 19.29%
Performance & Tape
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.25
- Avg Volume
- 18.54K
Get TickerSpark's AI analysis on SRBCF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SRBCF Coverage
We haven't published any research on SRBCF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SRBCF Report →